Internal Medicine, Endocrinology, Diabetes, & Metabolism · Newark, OH
NPI
1104080977
Since 2008
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1272 West Main Street, Suite 204
Newark, OH, 43055
Phone (220) 564-1740
Groups this clinician bills Medicare through
Medicare paid, 2024
$9,965
297 services
Medicare patients, 2024
113
Average age 70
Drug cost, 2024
$1.3M
2,879 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marco M de Santis was code 99214 (office e&m - established), 102 times for 93 patients. In total Marco M de Santis billed 297 services in 10 codes, and Medicare paid $9,965.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-08-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 102 | 93 | $65.32 | $6,663 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 63 | 62 | $11.14 | $702 |
| 82962 Clinical Chemistry | Office | 51 | 48 | $3.15 | $161 |
| 83036 Blood Count | Office | 27 | 26 | $9.52 | $257 |
| 95251 Test - Miscellaneous | Office | 27 | 23 | $21.38 | $577 |
| 99213 Office E&M - Established | Office | 17 | 16 | $40.06 | $681 |
By year: 2022 $26K for 553 services; 2023 $26K for 547 services; 2024 $9,965 for 297 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 51 | 48 | $3.15 | $161 |
| 83036 Blood Count | 27 | 26 | $9.52 | $257 |
Medicare prescription drug claims, 2024
In 2024, the drug Marco M de Santis prescribed most often to Medicare patients was Levothyroxine Sodium, with 327 prescriptions and refills. In total Marco M de Santis wrote 2,879 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 327 | 766 | 91 | $2,967 |
| Metformin Hcl Generic | 152 | 396 | 50 | $1,365 |
| Ozempic Semaglutide | 127 | 220 | 35 | $217K |
| Metformin Hcl Er Metformin Hcl | 110 | 313 | 35 | $1,263 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 109 | 221 | 34 | $19K |
| Trulicity Dulaglutide | 93 | 138 | 28 | $134K |
| Novolog Flexpen Insulin Aspart | 90 | 145 | 26 | $29K |
| Jardiance Empagliflozin | 86 | 178 | 26 | $101K |
| Atorvastatin Calcium Generic | 83 | 219 | 26 | $691 |
| Methimazole Generic | 83 | 177 | 24 | $784 |
| Synthroid Levothyroxine Sodium | 80 | 180 | 24 | $6,867 |
| Ultra-Fine Short Pen Needle Pen Needle, Diabetic | 58 | 103 | 20 | $7,348 |
| Tresiba Flextouch U-200 Insulin Degludec | 55 | 108 | 14 | $94K |
| Glimepiride Generic | 55 | 129 | 16 | $307 |
| Mounjaro Tirzepatide | 43 | 43 | Under 11 | $43K |
Brand drugs: 1,427 claims; generic drugs: 1,222 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Marco M de Santis were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.